Session: 703. Cellular Immunotherapies: Basic and Translational: Poster II
Hematology Disease Topics & Pathways:
Fundamental Science, Research, Translational Research, GVHD, Diseases, Immune Disorders
Methodology: To investigate the suppressive capacity of NKreg cells, the cells were isolated from healthy donor peripheral blood and co-cultured with allogeneic CD4+ T cells, CD8+ T cells, Treg cells, Treg cells and dendritic cells, B cells, or NK cells for 96hrs. After 96hrs, the proliferation and viability of the responder cells were evaluated via proliferation dye dilution, and 7-AAD dye, respectively. To determine if the CD4+ T cell suppression is specific to a T helper (Th) cell subset we stained the co-cultured cells with a Th1/Th2/Th17 Phenotyping Kit. Further, PD-1 and LAG-3 neutralizing antibodies were added to the NKreg/CD4+ T cell co-culture to determine the receptor dependence. All samples were acquired with the BD FACSymphony Flow Cytometer and the data was analyzed via Kaluza software.
Results: CD56brightCD16-perforin- NKreg cells strongly suppress CD4+ T cell proliferation (approximately 96% suppression of CD4+ T cell proliferation at the 1:1 ratio of NKreg cells to CD4+ T cells). The contact-dependent mechanism of NKreg suppression of CD4+ T cell proliferation was significantly decreased when blocking either the PD-1 (15% decrease in suppression, p=0.03), or LAG-3 (29% decrease in suppression, p=0.04) receptors, at the 1:2 ratio of NKreg cells to CD4+ T cells. When both receptors are blocked the inhibition of suppressive effect is comparable to that of the LAG-3 blocking antibody being added individually (30% decrease in suppression, p=0.03). The suppressive mechanism of NKreg cells was observed to be selective in that they strongly suppress CD4+ T cell proliferation, but do not result in statistically significant suppression of CD8+ T cell, Treg cell, B cell, NK cell, or a specific Th cell subset proliferation (p>0.05). Further, though the average proliferation of the Treg cells co-cultured with NKreg cells and dendritic cells compared to just NKreg cells was greater (127% proliferation compared to 100% proliferation, respectively), we did not observe NKreg cells to induce a statistically significant proliferative effect towards the Treg cells in the presence of dendritic cells.
Conclusion: As a result of our studies, we have confirmed the NKreg cell immune suppressive function towards CD4+ T cell proliferation, a main contributor to cGvHD development. Further, we demonstrated a PD-1/LAG-3-dependent direct contact mechanism of NKreg cell suppression, which is selective of total CD4+ T cells, with a lack of suppressive effect towards CD8+ T cells, Treg cells, B cells, and NK cells. The results of these studies contribute to our better understanding of how NKreg cells may induce a cell-specific suppressive function to promote immune tolerance, providing potential cell therapeutic applications for enhancing NKreg cell suppressive function through increasing PD-1/LAG-3 ligand or receptor expression on NKreg cells.
Disclosures: No relevant conflicts of interest to declare.
See more of: Oral and Poster Abstracts